Fabio Marra Selected Research

Fabio Marra Research Topics

Disease

39	Fibrosis (Cirrhosis) 04/2022 - 09/2002
26	Neoplasms (Cancer) 05/2022 - 06/2003
21	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2009
20	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2007
19	Inflammation (Inflammations) 01/2019 - 07/2002
16	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2002
12	Liver Diseases (Liver Disease) 04/2022 - 06/2009
9	Cholangiocarcinoma 01/2022 - 10/2012
8	Fatty Liver 11/2017 - 01/2010
6	Liver Neoplasms (Liver Cancer) 08/2021 - 03/2007
5	Thrombosis (Thrombus) 03/2021 - 01/2015
5	Hypoxia (Hypoxemia) 09/2015 - 12/2005
4	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2021 - 03/2016
4	Hepatitis 01/2020 - 07/2002
4	Ascites 01/2020 - 04/2011
4	Obesity 03/2018 - 01/2002
3	Alcoholic Fatty Liver 04/2022 - 05/2008
3	Portal Hypertension 01/2022 - 01/2019
3	Disease Progression 01/2022 - 09/2016
3	Hypertension (High Blood Pressure) 01/2021 - 08/2008
3	Type 2 Diabetes Mellitus (MODY) 12/2020 - 08/2008
3	Hepatic Encephalopathy 01/2020 - 01/2015
3	Atherosclerosis 01/2019 - 08/2008
3	End Stage Liver Disease 01/2019 - 01/2018
3	Insulin Resistance 07/2011 - 09/2009
2	Cicatrix (Scar) 04/2022 - 08/2005
2	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 02/2017
2	Fatigue 07/2021 - 01/2021
2	Weight Gain 01/2021 - 01/2020
2	Cholestasis 01/2021 - 08/2005
2	Neoplasm Metastasis (Metastasis) 08/2020 - 10/2012
2	Hemorrhage 01/2020 - 01/2018
2	Metabolic Diseases (Metabolic Disease) 01/2019 - 01/2016
2	Chronic Hepatitis C 03/2016 - 10/2003
2	Hepatitis C 10/2013 - 09/2009
2	Virus Diseases (Viral Diseases) 09/2009 - 09/2002
1	Skin Neoplasms (Skin Cancer) 05/2022
1	Autoimmune Diseases (Autoimmune Disease) 04/2022
1	COVID-19 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Adenocarcinoma 01/2022

Drug/Important Bio-Agent (IBA)

9	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 01/2014
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2014
7	AdipokinesIBA 03/2018 - 12/2006
6	CytokinesIBA 01/2022 - 12/2006
6	ChemokinesIBA 08/2020 - 09/2002
6	Biological ProductsIBA 03/2018 - 09/2002
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 04/2010
5	Antiviral Agents (Antivirals)IBA 01/2019 - 10/2013
4	Pharmaceutical PreparationsIBA 11/2021 - 03/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2012 - 12/2005
4	LeptinIBA 08/2011 - 05/2002
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2022 - 03/2016
3	c-Mer Tyrosine KinaseIBA 04/2022 - 03/2016
3	Phospholipases (Phospholipase)IBA 09/2019 - 01/2017
2	LipidsIBA 01/2022 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 03/2021
2	lenvatinibIBA 11/2021 - 01/2021
2	Transaminases (Aminotransferases)IBA 07/2021 - 02/2008
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020 - 02/2008
2	Angiogenesis InhibitorsIBA 11/2020 - 06/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 11/2018 - 01/2014
2	Methionine (L-Methionine)FDA Link 10/2016 - 10/2012
2	Choline (Choline Chloride)IBA 10/2016 - 10/2012
2	LigandsIBA 03/2016 - 10/2012
2	Tissue Inhibitor of Metalloproteinase-1IBA 07/2014 - 01/2010
2	Triglycerides (Triacylglycerol)IBA 01/2014 - 05/2013
2	CurcuminIBA 01/2014 - 01/2010
2	AdiponectinIBA 09/2009 - 02/2008
2	NF-kappa B (NF-kB)IBA 05/2008 - 12/2006
1	Monoclonal AntibodiesIBA 04/2022
1	Bile Pigments (Bilin)IBA 01/2022
1	erucylphosphocholineIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	InterleukinsIBA 01/2022
1	CarbohydratesIBA 01/2022
1	Oncostatin MIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	Small Interfering RNA (siRNA)IBA 10/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	Mitogen-Activated Protein Kinase 7IBA 10/2021
1	Antineoplastic Agents (Antineoplastics)IBA 09/2021
1	Bevacizumab (Avastin)FDA Link 07/2021
1	Immune Checkpoint InhibitorsIBA 07/2021
1	tremelimumabIBA 07/2021

Therapy/Procedure

17	Therapeutics 01/2022 - 05/2008
11	Liver Transplantation 05/2022 - 08/2016
4	Transjugular Intrahepatic Portasystemic Shunt 01/2020 - 01/2015
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2022 - 01/2019
3	Radiofrequency Ablation 01/2021 - 08/2016
2	Transplantation 01/2022 - 01/2020
2	Contraindications 02/2020 - 01/2020
1	Biological Therapy 04/2022
1	Immunotherapy 11/2021
1	Drug Therapy (Chemotherapy) 10/2021
1	Subcutaneous Injections 10/2021
1	Surgical Instruments (Clip) 08/2021